Carboxyl-terminal domain of MUC16 imparts tumorigenic and metastatic functions through nuclear translocation of JAK2 to pancreatic cancer cells.

Carboxyl-terminal domain of MUC16 imparts tumorigenic and metastatic functions through nuclear translocation of JAK2 to pancreatic cancer cells.
复制标题

DOI:
10.18632/oncotarget.3308
复制
发表时间:
2015-03-20
期刊:
影响因子:
--
通讯作者:
Batra SK
Batra SK
中科院分区:
其他
文献类型:
--
作者:
Das S;Rachagani S;Torres-Gonzalez MP;Lakshmanan I;Majhi PD;Smith LM;Wagner KU;Batra SK

文献摘要

参考文献

被引文献

相似文献

MUC 16(CA 125)是一种I型跨膜糖蛋白,在包括胰腺癌(PC)在内的多种癌症中上调。然而,羧基末端MUC 16在PC中裂解后产生的存在和作用尚不清楚。我们之前的研究使用了系统的双表位标记的结构域删除羧基末端MUC 16的方法已经证明了17 kDa切割的MUC 16(MUC 16-Cter)的产生。在这里,我们使用MUC 16(F114 HA)的114个羧基末端残基的双表位标记版本(N-末端FLAG-和C-末端HA-标记)证明了MUC 16-Cter在PC中的功能意义。使用F114 HA转染的MiaPaCa-2和T3 M4细胞的体外分析显示,具有细胞凋亡抗性的G2/M期细胞的增殖、运动性和积累增加,这是与癌症干细胞(CSC)相关的特征。这得到了ALDH+ CSC的富集沿着增强的耐药性的支持。从机制上讲,我们证明了MUC 16-Cter的一种新功能,它促进JAK 2的核转位,导致组蛋白-3磷酸化上调干细胞特异性基因LMO 2和NANOG。使用Jak 2 +/+和Jak 2 −/−电池证明了Jak 2依赖性。使用eGFP-荧光素酶标记的细胞,我们证明了MUC 16-Cter在体内增强的致瘤性和转移潜力。综上所述,我们证明MUC 16-Cter介导的CSC富集是PC细胞的致瘤性、转移性和耐药性的部分原因。
MUC16 (CA125) is a type-I transmembrane glycoprotein that is up-regulated in multiple cancers including pancreatic cancer (PC). However, the existence and role of carboxyl-terminal MUC16 generated following its cleavage in PC is unknown. Our previous study using a systematic dual-epitope tagged domain deletion approach of carboxyl-terminal MUC16 has demonstrated the generation of a 17-kDa cleaved MUC16 (MUC16-Cter). Here, we demonstrate the functional significance of MUC16-Cter in PC using the dual-epitope tagged version (N-terminal FLAG- and C-terminal HA-tag) of 114 carboxyl-terminal residues of MUC16 (F114HA). In vitro analyses using F114HA transfected MiaPaCa-2 and T3M4 cells showed enhanced proliferation, motility and increased accumulation of cells in the G2/M phase with apoptosis resistance, a feature associated with cancer stem cells (CSCs). This was supported by enrichment of ALDH+ CSCs along with enhanced drug-resistance. Mechanistically, we demonstrate a novel function of MUC16-Cter that promotes nuclear translocation of JAK2 resulting in phosphorylation of Histone-3 up-regulating stemness-specific genes LMO2 and NANOG. Jak2 dependence was demonstrated using Jak2+/+ and Jak2−/− cells. Using eGFP-Luciferase labeled cells, we demonstrate enhanced tumorigenic and metastatic potential of MUC16-Cter in vivo. Taken together, we demonstrate that MUC16-Cter mediated enrichment of CSCs is partly responsible for tumorigenic, metastatic and drug-resistant properties of PC cells.
DOI: 10.1186/1471-2407-10-166
发表时间: 2010-04-28
期刊: BMC cancer
影响因子: 3.8
作者:
Harper LJ;Costea DE;Gammon L;Fazil B;Biddle A;Mackenzie IC
通讯作者: Mackenzie IC
人类胚胎干细胞,结肠癌和黑色素瘤细胞系中CD133表位的细胞周期依赖性变化。
DOI: 10.1158/0008-5472.can-08-0723
发表时间: 2008-10-01
期刊: CANCER RESEARCH
影响因子: 11.2
作者:
Jaksch, Marie;Munera, Jorge;Bajpai, Ruchi;Terskikh, Alexey;Oshima, Robert G.
通讯作者: Oshima, Robert G.
DOI: 10.1186/1476-4598-13-129
发表时间: 2014-05-29
期刊: Molecular cancer
影响因子: 37.3
作者:
Felder M;Kapur A;Gonzalez-Bosquet J;Horibata S;Heintz J;Albrecht R;Fass L;Kaur J;Hu K;Shojaei H;Whelan RJ;Patankar MS
通讯作者: Patankar MS
DOI: 10.1002/cncr.25203
发表时间: 2010-06-15
期刊: CANCER
影响因子: 6.2
作者:
Bast, Robert C., Jr.
通讯作者: Bast, Robert C., Jr.
DOI: 10.1038/srep01870
发表时间: 2013
期刊: Scientific reports
影响因子: 4.6
作者:
Chen SH;Hung WC;Wang P;Paul C;Konstantopoulos K
通讯作者: Konstantopoulos K